Delivery Order SPE2DB22D3010-SPE2DB25FP3CJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Jardiance 25 mg tablets (90-count units) under a firm fixed price contract valued at $10,700.20. The order, with an ultimate completion date of July 21, 2025, was competitively awarded without set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery to support federal medical procurement needs....
- The Defense Logistics Agency awarded a $19,435.63 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price contract was awarded competitively with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $25,383.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded contract, which carries no set-aside designation, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $62,937.18 delivery order from the Defense Logistics Agency (DLA) for 90 tablets of Jardiance 25 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. The award was made under firm fixed-price terms with no set-aside designation, indicating it was competitively awarded. This delivery order is issued as a child contract under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $20,706.62 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90 units. This is a firm fixed-price delivery order with a completion deadline of July 30, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $14,267.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $30,510.78 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) under a firm fixed price contract. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,987.82 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) under a firm fixed price contract type. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract valued at $11,743.92, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3CJDelivery Order
The Defense Logistics Agency awarded a $25,258.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, with an ultimate completion date of August 4, 2025. This non-set-aside contract is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order represents a routine pharmaceutical procurement action through the company's existing contract vehicle, which authorizes supply of a comprehensive range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other military healthcare systems. Jardiance, a diabetes management medication, falls within the therapeutic domains covered under the prime contract. The company's federal contracting portfolio demonstrates consistent capability in delivering pharmaceutical products through competitive, firm fixed price delivery orders, positioning it as a key supplier within the DLA's Medical Supply Chain. Performance of this order is scheduled at the company's Conshohocken, Pennsylvania location.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.3k | 8/1/25 |